Evolution of relative survival for acute promyelocytic leukemia patients alive at landmark time-points: a population-based study
Leukemia
.
2018 Oct;32(10):2263-2303.
doi: 10.1038/s41375-018-0054-8.
Epub 2018 Feb 23.
Authors
Jorne Lionel Biccler
1
2
,
Lene Sofie Granfeldt Østgård
3
,
Marianne Tang Severinsen
4
5
,
Claus Werenberg Marcher
6
,
Peter Møller
7
,
Claudia Schöllkopf
8
,
Lone Smidstrup Friis
9
,
Martin Bøgsted
4
5
,
Lasse Hjort Jakobsen
4
5
,
Tarec Christoffer El-Galaly
4
5
,
Jan Maxwell Nørgaard
3
Affiliations
1
Department of Haematology, Aalborg University Hospital, Aalborg, Denmark. j.biccler@rn.dk.
2
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. j.biccler@rn.dk.
3
Department of Haematology, Aarhus University Hospital, Aarhus, Denmark.
4
Department of Haematology, Aalborg University Hospital, Aalborg, Denmark.
5
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
6
Department of Haematology, Odense University Hospital, Odense, Denmark.
7
Department of Haematology, Roskilde Hospital, Roskilde, Denmark.
8
Department of Haematology, Herlev Hospital, Herlev, Denmark.
9
Department of Haematology, Rigshospitalet, Copenhagen, Denmark.
PMID:
29476132
DOI:
10.1038/s41375-018-0054-8
No abstract available
MeSH terms
Adolescent
Adult
Aged
Female
Humans
Leukemia, Promyelocytic, Acute / drug therapy
Leukemia, Promyelocytic, Acute / mortality*
Male
Middle Aged
Registries
Survival Rate
Tretinoin / therapeutic use
Young Adult
Substances
Tretinoin